The yield sign is a pretty big deal, at least for
Post# of 1525
With the financial information from 2013-2015 from filed financial reports, company performance in general, and OTC Pink with Current Information status - I will be very comfortable with full non-discounted valuation.
With no debt and no dilution, the company and management track record and the 2016 goals from the Open Letter to Shareholders, there is signification future value added, improving company/stock valuation further.
When I posted about the yield sign in November, I said that I discounted my price target by 50% due to the "Limited Information" status. If other investors - especially those who are only just learning about Progressive Care (RXMD) - have a similar sentiment concerning the "Limited Information" status... then it follows that, when the yield sign is removed, we have quite a bit of upside correction stimulus that should play out. Of course it will take some time for this to play out as, one by one, new investors see clearly how under-valued RXMD stock is. Over time, the price will correct to reflect "no more discounting of valuation" due to the prior Limited Information status. I won't be expecting the price to fully correct above .05 the day the yield sign comes down